×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| BIOFIL CHEMICALS & PHARMACEUTI | 92.65 | 24.11 | 64.33 | 1.48 | 67.6 | 24.2 |
| Concord Drugs Limited | NA | NA | NA | NA | 66.2 | 154.0 |
| GODAVARI DRUGS LTD. | NA | NA | NA | NA | 65.2 | 17.2 |
Biofil Chemicals & Pharmaceuticals, with Security Code 524396, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.6 | 2.4 | 17.4 | 5.0 | 15.2 | 8.4 | 2.4 | 14.2 | 8.4 | 6.4 |
| Expenses | 13.2 | 2.0 | 17.1 | 4.8 | 15.2 | 8.1 | 2.3 | 13.9 | 8.2 | 6.4 |
| Operating Profit | 0.4 | 0.4 | 0.2 | 0.2 | 0.0 | 0.3 | 0.1 | 0.3 | 0.1 | 0.0 |
| OPM % | 3% | 17.17% | 1.38% | 3.84% | -0.22% | 3.65% | 5.18% | 2.16% | 1.7% | 0.09% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.2 | 2.8 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Profit before tax | 0.3 | 0.3 | 0.2 | 0.1 | 0.3 | 0.2 | 0.0 | 0.2 | 0.3 | 2.8 |
| Tax % | -35.3% | -24.7% | -19.6% | -17.7% | -9.5% | 25.9% | -24.2% | 25.7% | 0% | 12.7% |
| Net Profit | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.0 | 0.2 | 0.2 | 2.4 |
| EPS in Rs | 0.07 | 0.15 | 0.08 | 0.06 | 0.15 | 0.1 | 0.01 | 0.1 | 0 | 1.48 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 12% |
| 3 Years: | 4% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 8% |
| 3 Years: | -17% |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 27% |
| 3 Years: | -8% |
| 1 Year: | -32% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|